New drug combo tested to shrink breast tumors before surgery
NCT ID NCT01750073
Summary
This study tested whether adding the drug trastuzumab to standard chemotherapy before surgery helps shrink breast tumors more effectively. It involved 92 women with early-stage breast cancer who had not received prior treatment. The main goals were to see if the combination was safe and if it led to a complete disappearance of cancer in the removed tissue after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHI Health Saint Francis
Grand Island, Nebraska, 68803, United States
-
Nebraska Medicine-Bellevue
Bellevue, Nebraska, 68123, United States
-
Nebraska Medicine-Village Pointe Cancer Center
Omaha, Nebraska, 68118, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.